Insider Transactions and Holdings
-
Entity Type
-
Company
-
Role
-
Director
-
Stock Symbol
-
SABS, SABSW on Nasdaq
There are no Buy or Sell transactions made by Sessa Capital (Master), L.P. since 12/3/2024
Holdings reported by Sessa Capital (Master), L.P. for SAB Biotherapeutics, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
2.2M |
$3.85M |
$1.75 |
Sep 29, 2025 |
Direct |
|
|
| Series B Convertible Preferred Stock |
211K |
|
|
Sep 29, 2025 |
Direct |
Common Stock |
|
| Warrants (right to buy) |
114K |
|
|
Jul 22, 2025 |
Direct |
Series B Convertible Preferred Stock |
|
Transactions reported by Sessa Capital (Master), L.P. for SAB Biotherapeutics, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.